GlassScriptPhysician profile
Emily Cendrowski
NPI 1124481577
$7,602.24
in general payments reported to CMS, 2019-2025
18 companies · $2,696 in 2025
The $2,696 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.89 · 2020: $100 · 2022: $103 · 2023: $3,962 · 2024: $730 · 2025: $2,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,129 · Food and Beverage: $3,258 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,128.94 |
| Food and Beverage | $3,257.66 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,081.19 | 2023-2025 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,824.77 | 2023 | Optis, Xience Skypoint |
| Abiomed | $728.37 | 2023-2025 | Impella |
| Boston Scientific Corporation | $216.19 | 2024-2025 | Avvigo Guidance System, Watchman Access System |
| Shockwave Medical, INC | $169.21 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.03 | 2020-2025 | Lifevest |
| Philips North America LLC | $102.75 | 2022 | |
| Siemens Medical Solutions USA, INC. | $99.72 | 2024-2025 | Acuson Origin Diagnostic Ultrasound System |
| Medtronic, INC. | $87.30 | 2023-2025 | Corevalve Evolut R |
| Kestra Medical Technology Services, INC. | $49.60 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $22.98 | 2025 | Eliquis |
| Cvrx, INC. | $19.51 | 2025 | Barostim Neo System |
| Amgen INC. | $15.96 | 2025 | Repatha |
| Scpharmaceuticals INC. | $15.74 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $15.61 | 2024 | Brilinta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.50 | 2025 | Verquvo |
| Heartflow, INC. | $13.92 | 2025 | |
| Getinge USA Sales, LLC | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Cendrowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.